Explore
Trendline
Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community
Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community
Read More
Trendline
Arcturus Therapeutics to Announce Q1 Financial Results and Corporate Update
Arcturus Therapeutics to Announce Q1 Financial Results and Corporate Update
Read More
Trendline
Simpson Manufacturing Reports Strong Q1 2026 Earnings Amid Housing Market Challenges
Simpson Manufacturing Reports Strong Q1 2026 Earnings Amid Housing Market Challenges
Read More
Trendline
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call
Read More
Trendline
ADC Therapeutics Announces Upcoming Financial Results Conference Call for Q1 2026
ADC Therapeutics Announces Upcoming Financial Results Conference Call for Q1 2026
Read More
Trendline
ADC Therapeutics Announces First Quarter 2026 Financial Results Call
ADC Therapeutics Announces First Quarter 2026 Financial Results Call
Read More
Trendline
ImmunityBio Faces Securities Fraud Class Action Over Misleading Statements
ImmunityBio Faces Securities Fraud Class Action Over Misleading Statements
Read More
Trendline
Ituran Location and Control Ltd. Announces First Quarter 2026 Results Release and Conference Call
Ituran Location and Control Ltd. Announces First Quarter 2026 Results Release and Conference Call
Read More
Trendline
Ituran Location and Control Ltd. Announces Q1 2026 Results Release
Ituran Location and Control Ltd. Announces Q1 2026 Results Release
Read More
Trendline
Domino's Pizza Reports 3.5% Revenue Increase in Q1 2026 Amid Competitive Market
Domino's Pizza Reports 3.5% Revenue Increase in Q1 2026 Amid Competitive Market
Read More
Trendline
U.S. Faces Challenges in Biotech Race Against China, Highlights Innovation and Regulatory Hurdles
U.S. Faces Challenges in Biotech Race Against China, Highlights Innovation and Regulatory Hurdles
Read More
Trendline
Rosen Law Firm Investigates Disc Medicine Over Securities Claims Following FDA Rejection
Rosen Law Firm Investigates Disc Medicine Over Securities Claims Following FDA Rejection
Read More